BENEFIT: Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immuno-suppression Trial
|Effective start/end date||3/14/06 → 12/1/15|
- BRISTOL-MYERS SQUIBB PHARM RES
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.